J&J and Smith & Nephew orthopaedics merger collapses
The planned combination would have created a $34bn medical technology company. It fell apart after London-listed Smith & Nephew refused to agree to its former chief executive leading the merged business.
The deal would have joined Johnson & Johnson's orthopaedics business with Smith & Nephew. The $34bn figure is the combined value of the proposed transatlantic company.
Reports said Smith & Nephew would not accept its former chief executive as head of the merged business. That dispute ended the talks.
Key facts
- Who
- Johnson & Johnson (owner of the orthopaedics business proposed for the combination); Smith & Nephew (London-listed group that refused to agree to the former chief executive…)
- What
- A planned combination of Johnson & Johnson's orthopaedics business with Smith & Nephew, which would have created a $34bn medical technology company, collapsed after the London-listed group refused to agree to its former chief executive leading the merged business. The report is based on an FT exclusive; only the description and headline were provided.
- When
- 23 October 2026
- Status
- Reported